Qingdao Baheal Medical INC. (SHE: 301015)
China
· Delayed Price · Currency is CNY
27.38
-0.11 (-0.40%)
Oct 10, 2024, 3:01 PM CST
Qingdao Baheal Medical INC. Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
Operating Revenue | 7,564 | 7,564 | 7,494 | 7,030 | 5,864 | 4,835 | Upgrade
|
Other Revenue | - | - | 15.19 | 22 | 15.19 | 13.87 | Upgrade
|
Revenue | 7,564 | 7,564 | 7,510 | 7,052 | 5,879 | 4,849 | Upgrade
|
Revenue Growth (YoY) | 0.72% | 0.72% | 6.50% | 19.94% | 21.26% | 32.75% | Upgrade
|
Cost of Revenue | 5,297 | 5,297 | 5,426 | 5,277 | 4,415 | 3,499 | Upgrade
|
Gross Profit | 2,267 | 2,267 | 2,084 | 1,774 | 1,464 | 1,350 | Upgrade
|
Selling, General & Admin | 1,300 | 1,300 | 1,319 | 1,130 | 1,013 | 983.55 | Upgrade
|
Research & Development | 11.34 | 11.34 | 3.32 | - | - | - | Upgrade
|
Other Operating Expenses | 17.81 | 17.81 | 36.05 | 31.54 | 27.11 | 25.13 | Upgrade
|
Operating Expenses | 1,329 | 1,329 | 1,371 | 1,160 | 1,050 | 1,015 | Upgrade
|
Operating Income | 938.23 | 938.23 | 712.6 | 614.75 | 413.73 | 334.43 | Upgrade
|
Interest Expense | - | - | -58.07 | -61.08 | -62.24 | -55.96 | Upgrade
|
Interest & Investment Income | 43.01 | 43.01 | 9.44 | 10.92 | 17.98 | 21.66 | Upgrade
|
Currency Exchange Gain (Loss) | - | - | 6.42 | -2.38 | -3.23 | -2.95 | Upgrade
|
Other Non Operating Income (Expenses) | -103.56 | -103.56 | -4.99 | -15.22 | -5.88 | -2.93 | Upgrade
|
EBT Excluding Unusual Items | 877.68 | 877.68 | 665.4 | 547 | 360.35 | 294.26 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.62 | 0.62 | -10.75 | 5.87 | 4.21 | - | Upgrade
|
Gain (Loss) on Sale of Assets | -6.57 | -6.57 | 0.57 | 0.1 | 0.48 | 0.04 | Upgrade
|
Asset Writedown | 1.85 | 1.85 | -0.04 | -0.01 | -0.14 | -0.44 | Upgrade
|
Other Unusual Items | - | - | 13.38 | 12.46 | 5.98 | -1.39 | Upgrade
|
Pretax Income | 873.58 | 873.58 | 668.55 | 565.42 | 370.89 | 292.48 | Upgrade
|
Income Tax Expense | 233.69 | 233.69 | 183.15 | 150.4 | 93.66 | 81.51 | Upgrade
|
Earnings From Continuing Operations | 639.88 | 639.88 | 485.4 | 415.02 | 277.22 | 210.97 | Upgrade
|
Minority Interest in Earnings | 16.42 | 16.42 | 16.68 | 6.63 | -4.51 | -1.09 | Upgrade
|
Net Income | 656.31 | 656.31 | 502.09 | 421.64 | 272.71 | 209.87 | Upgrade
|
Net Income to Common | 656.31 | 656.31 | 502.09 | 421.64 | 272.71 | 209.87 | Upgrade
|
Net Income Growth | 29.55% | 30.71% | 19.08% | 54.61% | 29.94% | -18.69% | Upgrade
|
Shares Outstanding (Basic) | 525 | 525 | 523 | 496 | 470 | 473 | Upgrade
|
Shares Outstanding (Diluted) | 534 | 534 | 523 | 496 | 470 | 473 | Upgrade
|
Shares Change (YoY) | 1.11% | 2.02% | 5.44% | 5.50% | -0.49% | - | Upgrade
|
EPS (Basic) | 1.25 | 1.25 | 0.96 | 0.85 | 0.58 | 0.44 | Upgrade
|
EPS (Diluted) | 1.23 | 1.23 | 0.96 | 0.85 | 0.58 | 0.44 | Upgrade
|
EPS Growth | 28.13% | 28.13% | 12.94% | 46.55% | 30.58% | -18.69% | Upgrade
|
Free Cash Flow | 480.47 | 480.47 | 200.43 | 153.81 | -133.19 | 40.04 | Upgrade
|
Free Cash Flow Per Share | 0.90 | 0.90 | 0.38 | 0.31 | -0.28 | 0.08 | Upgrade
|
Dividend Per Share | - | - | 0.762 | 0.667 | - | - | Upgrade
|
Dividend Growth | - | - | 14.24% | - | - | - | Upgrade
|
Gross Margin | 29.98% | 29.98% | 27.75% | 25.16% | 24.90% | 27.84% | Upgrade
|
Operating Margin | 12.40% | 12.40% | 9.49% | 8.72% | 7.04% | 6.90% | Upgrade
|
Profit Margin | 8.68% | 8.68% | 6.69% | 5.98% | 4.64% | 4.33% | Upgrade
|
Free Cash Flow Margin | 6.35% | 6.35% | 2.67% | 2.18% | -2.27% | 0.83% | Upgrade
|
EBITDA | 968.17 | 968.17 | 735.93 | 636.6 | 433.31 | 351.9 | Upgrade
|
EBITDA Margin | 12.80% | 12.80% | 9.80% | 9.03% | 7.37% | 7.26% | Upgrade
|
D&A For EBITDA | 29.94 | 29.94 | 23.33 | 21.85 | 19.59 | 17.47 | Upgrade
|
EBIT | 938.23 | 938.23 | 712.6 | 614.75 | 413.73 | 334.43 | Upgrade
|
EBIT Margin | 12.40% | 12.40% | 9.49% | 8.72% | 7.04% | 6.90% | Upgrade
|
Effective Tax Rate | 26.75% | 26.75% | 27.39% | 26.60% | 25.25% | 27.87% | Upgrade
|
Revenue as Reported | - | - | 7,510 | 7,052 | 5,879 | 4,849 | Upgrade
|
Advertising Expenses | - | - | 1.01 | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.